Cable de conexión con botón para electrodos

Información básica

• Disponible en:
• English
• Español

Product Description:

The EarlyTect Colon Cancer Test is a revolutionary screening tool specifically developed for the detection of colorectal cancer. This product has undergone rigorous clinical trials at prestigious medical institutions, including the Yonsei Medical Center, Severance Hospital, and Severance Check-up Center. Approved by the Korea Ministry of Food and Drug Safety, this test offers immense accuracy and reliability.

Utilizing fecal DNA testing, the EarlyTect Colon Cancer Test can diagnose colorectal cancer with an impressive 90% sensitivity and specificity. By measuring the levels of methylated Syndecan-2, a biomarker closely associated with precancerous lesions of colorectal cancer, this qualitative real-time PCR test delivers accurate and swift results.

It is important to note that the EarlyTect Colon Cancer Test is not intended to confirm the presence of colorectal cancer itself. Instead, it serves as a valuable tool for identifying potential indicators of the disease, such as precancerous lesions. A positive result from this test indicates the need for further medical evaluation to investigate the possibility of colorectal cancer or precancerous lesions.

Product Standard:

- Cancer Type: Colorectal Cancer
- Suitable for: Asymptomatic individuals for colorectal cancer screening
- Biomarker: SDC2 methylation

Pricing and transaction conditions are flexible and open to negotiation. To obtain a quote, please submit a request via the provided link.